Google
ARAY 株価分析 — Accuray Incorporated (Healthcare >> Medical Devices)
ARAY に関するよくある質問
ARAYのPER（株価収益率）は？
Accuray Incorporated（ARAY）は現在PER 30.31倍で取引されています。
ARAYのROE（自己資本利益率）は？
Accuray IncorporatedのROEは-110.60%です。
ARAYの配当利回りは？
Accuray Incorporatedの配当利回りは0.00%です。
ARAYの品質スコア（Quality Score）は？
当社のAIはARAYの総合財務品質を100点中46点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
ARAYは今が買い時ですか？
当社AIのタイミングスコアは100点中26点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
ARAYはどのセクターに属しますか？
Accuray IncorporatedはHealthcare >> Medical Devicesセクターに分類されます（NASDAQ市場）
ARAY AI Analysis Summary
Our AI summary for ARAY: Accuray Incorporated (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 30.31, ROE of -110.60%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 0.27
Price
-0.02
(-5.93%)
Day Change
|
|
|---|
ARAY, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
ROEが昨年度比で低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 93 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.27 |
| PBV / Sector |
0.82 / -101.57
GREAT
|
| Earning Per Share | -0.36 |
| PE / Sector |
30.31 / 31.23
|
| PEG or PE/Growth / Sector |
2.27 / 0.40
|
| Average 1M Daily Value |
0.37 M
GREAT
|
| Average 1W Daily Value |
0.71 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
37% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:29 |
| Symbol | ARAY |
| Name | ACCURAY INCORPORATED |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 119.43 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 34.04 / 20,104.97 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1240 Deming Way, Madison, WI, United States, 53717-1954
Phone: 608 824 2800
Website: https://www.accuray.com
Employees: 990
Sector: Healthcare >> Medical Devices
Description: Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
